Long-Term Stable Bone Mineral Density in HIV-Infected Men Without Risk Factors for Osteoporosis Treated with Antiretroviral Therapy.

Mark J BollandAnne M HorneSimon E BriggsMark G ThomasIan R ReidGreg D GambleAndrew Grey

Published in: Calcified tissue international (2019)

BMD remained stable over 12 years in middle-aged and older HIV-infected men treated with ART. Monitoring BMD in men established on ART who do not have risk factors for BMD loss is not necessary.

Keyphrases

hiv infected
antiretroviral therapy
bone mineral density
postmenopausal women
middle aged
human immunodeficiency virus
hiv infected patients
hiv positive
hiv aids
body composition
physical activity
community dwelling